Worldwide Clinical Trials Selects TransPerfect's Trial Interactive Platform as its eTMF Solution
TransPerfect
, a leading provider of e-clinical technologies to the
life sciences
industry, today announced that
Worldwide Clinical Trials
(WCT) has selected
Trial Interactive
as its electronic Trial Master File (eTMF) solution to streamline global study management. Trial Interactive is a web-based, 21 CFR Part 11 compliant platform that eliminates the redundancies inherent in paper-based TMF studies.
“With Trial Interactive as our eTMF solution, we will be able to deliver near real-time access to eTMFs for our clients, and we will improve overall processes in managing TMF documentation,” said Tom Wardle, Chief Operating Officer of WCT.
By providing study stakeholders with real-time access to
clinical trial documentation
, Trial Interactive eliminates travel and shipping costs associated with review and reconciliation, thereby streamlining clinical development programs for WCT and its sponsors. In addition, Trial Interactive’s interface is available in more than 20 languages, which will enable WCT to deploy the solution in the local language of the end user, including global study teams, sponsors, and investigative site personnel.
Michael Smyth, General Manager of TransPerfect Life Sciences Solutions, added, “We are proud that WCT has chosen Trial Interactive as its eTMF solution, and we’re pleased to support their ultimate goal of a paperless clinical trial.”
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
